VitalHub Corp. announced on August 15, 2025, a public equity offering of 5,118,111 common shares at a price of $12.70 each, for expected gross proceeds of approximately $65 million. The offering was made under an underwriting agreement with Cormark Securities Inc. and National Bank Financial Inc. as co-lead underwriters and joint bookrunners, joined by Canaccord Genuity Corp., Scotia Capital Inc., and TD Securities Inc.

Legal counsel included CP LLP and DLA Piper (Canada) LLP advising VitalHub, while Cassels Brock & Blackwell LLP acted for the underwriters. The shares were listed on the Toronto Stock Exchange under the symbol “VHI.” Proceeds were intended to support VitalHub’s acquisition strategy, along with general corporate purposes and working capital. An over-allotment option was granted to the underwriters.

On August 20, 2025, VitalHub closed the bought deal offering, issuing 5,885,828 common shares at $12.70 per share. The total gross proceeds amounted to approximately $74.75 million, reflecting the full exercise of the over-allotment option.